Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Glioblastoma 1Breast Neoplasms 1

Interventions

Fulvestrant 25Letrozole 23Specimen Handling 19ribociclib 15Capecitabine 15pembrolizumab 14palbociclib 13abemaciclib 12Trastuzumab 12Paclitaxel 12exemestane 11Tamoxifen 11Magnetic Resonance Spectroscopy 11Anastrozole 11Carboplatin 10trastuzumab deruxtecan 8pertuzumab 8Biopsy 8Goserelin 7inavolisib 6Cyclophosphamide 6giredestrant 5Taxes 5Radiotherapy 5130-nm albumin-bound paclitaxel 5pyrotinib 4patritumab deruxtecan 4olaparib 4eribulin 4elacestrant 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × 4-amino-4'-hydroxylaminodiphenylsulfone × 30 days × Clear all
NCT03975959 2026-06-04

PROMESSE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
426 enrolled
BreastCNS

Breast Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡